Apr 2, 2026 04:05PM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:00PM
Apr 2, 2026 04:00PM
Mar 10, 2026 06:00AM
Mar 3, 2026 06:00AM
Mar 3, 2026 06:00AM Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Jan 11, 2026 06:00PM
Dec 22, 2025 07:06AM
Dec 9, 2025 04:30PM
Nov 21, 2025 08:01AM
Nov 21, 2025 08:00AM
Nov 19, 2025 08:00AM
Nov 18, 2025 07:02AM NILEMDO receives Health Canada approval for LDL cholesterol reduction
Nov 18, 2025 07:00AM
Nov 10, 2025 08:00AM
Nov 6, 2025 04:30PM
Nov 6, 2025 06:00AM
Nov 4, 2025 08:00AM
Nov 4, 2025 08:00AM
Nov 3, 2025 08:00AM Esperion to Participate in Jefferies Global Healthcare Conference - London
Oct 28, 2025 08:00AM
Oct 27, 2025 08:00AM
Oct 23, 2025 08:00AM
Oct 16, 2025 08:00AM
Oct 7, 2025 09:29PM
Oct 7, 2025 09:29PM
Oct 7, 2025 04:02PM Esperion announces public offering of common stock
Oct 7, 2025 04:01PM
Oct 3, 2025 08:00AM
Oct 3, 2025 08:00AM
Sep 19, 2025 08:02AM
Sep 19, 2025 08:00AM
Aug 29, 2025 08:00AM
Aug 26, 2025 08:00AM Esperion to Participate in Upcoming September Investor Conferences
Aug 7, 2025 05:30PM
Aug 5, 2025 06:00AM
Jul 22, 2025 08:00AM
Jul 8, 2025 08:01AM
Jul 8, 2025 08:00AM
Jul 1, 2025 08:07AM
Jul 1, 2025 08:06AM Esperion Appoints Craig Thompson to Board of Directors
Jun 2, 2025 08:03AM
Jun 2, 2025 08:00AM
May 20, 2025 08:00AM
May 12, 2025 08:03AM
May 12, 2025 08:00AM
May 9, 2025 08:00AM
May 8, 2025 04:30PM Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 8, 2025 06:30AM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All